These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12510632)

  • 1. To treat or not to treat...when that is the question.
    Katz M
    Posit Living; 1999 Sep; 8(8):9, 57. PubMed ID: 12510632
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 3. OI prophylaxis in antiretroviral responders: stay the course or bite the bullet?
    Currier JS
    AIDS Clin Care; 1998 Oct; 10(10):73-5, 79-80. PubMed ID: 11365859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.
    TreatmentUpdate; 2004; 16(3):4-5. PubMed ID: 17219607
    [No Abstract]   [Full Text] [Related]  

  • 5. [The new age of HIV/AIDS. A special report on the XI International Conference on AIDS].
    Detres LL
    Sidahora; 1996; ():26-33. PubMed ID: 11364380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.
    Degen O; ven Lunzen J; Horstkotte MA; Sobottka I; Stellbrink HJ
    AIDS; 2002 Jul; 16(10):1433-4. PubMed ID: 12131226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pneumocystis pneumonia and generalized tuberculosis in HIV-infected patients].
    Mikhaĭlova NR; Ermak TN; Mikhaĭlovskiĭ AM
    Ter Arkh; 2013; 85(11):67-8. PubMed ID: 24432603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of Pneumocystis carinii pneumonia in HIV-1-infected patients responding to HAART: is prophylaxis discontinuation a safe tool?
    Mezzaroma I; Giovannetti A; Pinter E; Ensoli F; Aiuti F
    AIDS; 1999 Dec; 13(17):2488-9. PubMed ID: 10597798
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection masquerading as monoclonal gammopathy of unknown significance.
    Aslam A; Misbah SA
    N Engl J Med; 2003 Dec; 349(24):2362-3; author reply 2362-3. PubMed ID: 14668466
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The house is burning: an HIV clinician's view after 20 years.
    Follansbee S
    Focus; 2001 Aug; 16(9):1-5. PubMed ID: 11692445
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral rounds. CD4 count 423, viral load 12,000: time to treat anyway?
    Hodder S; Frank I
    AIDS Clin Care; 2006 Jun; 18(6):59-60. PubMed ID: 16791955
    [No Abstract]   [Full Text] [Related]  

  • 15. Withdrawal of prophylaxis against Pneumocystis carinii pneumonia.
    Feinberg J
    Lancet; 1999 Apr; 353(9161):1287. PubMed ID: 10218521
    [No Abstract]   [Full Text] [Related]  

  • 16. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
    Phillips P
    Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
    [No Abstract]   [Full Text] [Related]  

  • 17. P. carinii prophylaxis in patients with HIV.
    Kirchner JT
    Am Fam Physician; 1999 Nov; 60(7):2094-5. PubMed ID: 10569511
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy.
    Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J
    Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opportunistic AIDS-associated disorders strictly related to immunodeficiency levels, in a girl with congenital HIV infection.
    Manfredi R; Calza L; Chiodo F
    Int J STD AIDS; 2003 Sep; 14(9):638-9. PubMed ID: 14511504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
    Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
    J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.